Moreover, other senolytics targeting the AKT1/PI3K tested such as dasatinib + quercetin are toxic for both senescent DM1 myoblasts and healthy control cells, which suggests that this pathway is critical for myogenic cell viability. Here, AKT1 is linked to myotonic dystrophy type 1.